ICON plc (ICLR) is trading higher as investors react to the company’s April 29, 2026 update that its Audit Committee has completed an investigation into certain accounting practices and internal controls, reducing uncertainty around the process. The company said the investigation findings were primarily related to revenue recognition and that revenue was overstated in 2023 and 2024, with the overstatement in each year coming in below the previously communicated upper limit of 2%, while 2025 impacts were smaller than the prior years. (investor.iconplc.com)

The completed investigation narrows the range of potential outcomes and shifts investor focus toward execution: finishing the external audit, issuing final financial statements, and filing the delayed annual report. ICON said the finalization of financial statements and the external audit process are expected to be completed in the coming weeks, after which it plans to file its Annual Report on Form 20-F and include details on material weaknesses and remediation plans. (investor.iconplc.com)

In addition to the timing of audited financials, ICON indicated it intends to provide a broader business update, including backlog policy changes, recent business wins, and cancellation trends—items that can materially affect near-term growth expectations for a clinical research organization. Any changes to backlog disclosures or cancellations could influence how investors model 2026 demand and margins, especially after the reporting delay and restatement process. (investor.iconplc.com)